The Serious Adverse Events Consortiuma not-for-profit partnership of pharmaceutical
companies and academic institutions with input from the Food and Drug Administrationplans
to host a teleconference (1-800-909-5202) to discuss the groups formation and announce
two initial research programs to identify genetic markers that could help predict risk for
drug-related adverse events. The teleconference is scheduled for 11 a.m. to noon EDT on
Thursday, Sept. 27.